Pictet Asset Management’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$265K Hold
18,172
﹤0.01% 1829
2026
Q1
$250K Buy
18,172
+2,803
+18% +$42.2K ﹤0.01% 1813
2025
Q4
$277K Hold
15,369
﹤0.01% 1748
2025
Q3
$285K Sell
15,369
-1,246
-7% -$19.6K ﹤0.01% 1679
2025
Q2
$266K Buy
+16,615
New +$296K ﹤0.01% 1695
2025
Q1
Sell
-12,839
Closed -$283K 2023
2024
Q4
$283K Buy
+12,839
New +$247K ﹤0.01% 1673

Other funds holding CLBT

Pictet Asset Management's CLBT Position: Q2 2026 in Review

Pictet Asset Management held its Cellebrite (CLBT) position steady in Q2 2026 at 18,172 shares worth $265K. The position accounts for ﹤0.01% of the portfolio, ranked #1829.

Pictet Asset Management first reported a position in CLBT in Q4 2024 and has held it in 6 quarters since. The position peaked at $285K in Q3 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Pictet Asset Management held 18,172 shares of Cellebrite worth $265K as of Q2 2026.
  • Pictet Asset Management left its Cellebrite share count unchanged in Q2 2026.
  • Cellebrite made up ﹤0.01% of Pictet Asset Management's portfolio in Q2 2026, its #1829 holding.
  • Pictet Asset Management first reported a position in Cellebrite in Q4 2024 and has held it in 6 quarters since.
  • Pictet Asset Management's Cellebrite position peaked at $285K in Q3 2025.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.